Syros Pharmaceuticals snags $53 mln from Polaris, Flagship, ARCH Venture
Watertown, Mass.-based Syros Pharmaceuticals, which focuses on treating cancer and other diseases, has raised $53 million in Series B funding.
27 October 2014•1 min read
Watertown, Mass.-based Syros Pharmaceuticals, which focuses on treating cancer and other diseases, has raised $53 million in Series B funding.
